Abstract19F MRI is a unique technique for tracking and quantifying the indicator (19F‐MRI label) in vivo without the use of ionizing radiation. Here we report new 19F‐MRI labels, which are compounds with perfluoro‐tert‐butyl groups: 1,2‐bis(perfluoro‐tert‐butoxy)ethane (C10F18H4O2) and 1,3‐bis(perfluoro‐tert‐butyl)propane (C11F18H6). Both substances contain 18 equivalent 19F atoms, constituting 68.67 % and 71.25 % of the molecule, respectively. The emulsions with 19F molecules were prepared and used in 19F MRI studies in laboratory rats in vivo. The substances demonstrated high contrast properties, good biological inertness and the ability to be rapidly eliminated from the body. We showed that at a dose of 0.34 mg/g of body weight in rats, the time for complete elimination of C10F18H4O2 and C11F18H6 is ∼30 days. The results turned out to be promising for the use of the presented compounds in 19F MRI applications, especially since they are quite easy to synthesize.
摘要 19F MRI 是一种无需使用电离辐射即可在体内跟踪和量化指示剂(19F-MRI 标签)的独特技术。我们在此报告新的 19F-MRI 标签,它们是带有
全氟叔丁基的化合物:1,2-双(
全氟叔丁
氧基)
乙烷(C10F18H4O2)和
1,3-双(
全氟叔丁基)
丙烷(C11F18H6)。这两种物质都含有 18 个等效的 19F 原子,分别占分子的 68.67% 和 71.25%。制备了含有 19F 分子的乳剂,并将其用于实验室大鼠体内的 19F MRI 研究。这些物质具有高对比度特性、良好的
生物惰性和快速排出体外的能力。我们的研究表明,以大鼠体重 0.34 毫克/克的剂量计算,C10F18H4O2 和 C11F18H6 完全排出体外的时间为 30 天。研究结果表明,这些化合物很容易合成,因此有望用于 19F 磁共振成像。